A Review of Community Pharmacy-Based Pharmacologic Interventions and Methods for Smoking Cessation
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2013, Vol 1, Issue 1
Abstract
Background: The aim of this study was to provide an overview of the published peer-reviewed literature related to community pharmacy-based smoking cessation counseling efforts in the United States and Canada. Methods: Electronic databases, Embase, PubMed and Medline, were searched for articles from January 2002 to January 2012. Keywords used were smoking cessation, pharmacist, pharmacologic, pharmacy, and multidisciplinary. Studies were excluded if they were conducted outside of the United States and Canada. Results: Twenty-six articles were included in this review with subtopics pharmacist and patient perception of pharmacy-based counseling, pharmacologic interventions, and methods for pharmacist led smoking cessation counseling. Literature review suggests both patients and pharmacists have positive views on smoking cessation counseling by a pharmacist. Studies show that counseling related to pharmacologic interventions is preferred. Specifically, patients prefer a non-confrontational approach by pharmacists. Although the 2008 Clinical Practice Guidelines, Treating Tobacco Use and Dependence, recommend an intensive intervention approach due to a strong dose-response relationship between the session length and successful treatment outcomes, pharmacists are unlikely to use an intensive intervention. Pharmacists should perform brief counseling sessions by assessing a patient’s willingness to quit and then motivating, educating, and referring them to an available resource. These brief sessions should be done in person and performed at each visit. Conclusions: Pharmacists are encouraged to develop or adopt a system of tracking codes for smoking cessation counseling as efforts towards reimbursement increase in the future. Evidence suggests that cost reduction and improved health outcomes can occur when smoking cessation counseling is provided in the community pharmacy setting. Future research should examine reimbursement for pharmacistprovided counseling.
Authors and Affiliations
Annesha Lovett
Keywords
Related Articles
- EP ID EP197879
- DOI 10.13188/2327-204X.1000003
- Views 116
- Downloads 0
Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats
Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...
Use of Intravenous Acetaminophen to Reduce Opioid Use in Patients Undergoing Bariatric Surgery at a Community Teaching Hospital
Purpose: The use of intravenous (IV) acetaminophen has been evaluated in several clinical trials and systematic reviews and has been shown to be an effective pain medication that can reduce the need for opioids. Recently...
QbD Based Approach to Design Controlled Strategy for Wet Granulation Method Using Plackett Burman Design-Case Study
Objective: The objective of present work describes developing controlled strategy for wet granulation process by identifying critical process parameters and study was done using DoE in support of Quality by Design (QbD)....
Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3- Gallate Encapsulated in Chitosan Nanoparticles on Human Prostate Carcinoma Cells
(-)-epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, has shown excellent effects in preventing, as well as treating, many cancers including prostate cancer (PCa) in preclinical model systems. However...
NMDA Receptor Antagonism by Phencyclidine Reduces NWASP and WAVE1 Protein Expression and Reduces Levels of Myelination Markers in the Prefrontal Cortex of Rats
N-methyl-D-aspartate (NMDA) receptor antagonism by perinatal phencyclidine (PCP) treatment leads to neuronal damage and causes long-term behavioural alterations in rodents. It is routinely used to model pathological proc...